MJIC Inc. has added five new companies to the U.S. Marijuana Index as a result of its quarterly rebalancing.
Tag Archives: Volume
The Colorado Marijuana Enforcement Division recently issued its 2016 mid-year report, documenting supply chain data from Jan. 1 to June 30, 2016.
On April 21, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced it had received Orphan Drug Designation for cannabidiol in the treatment of Tuberous Sclerosis Complex.
Chris Bunka, the CEO and Chair at Lexaria Corp. (CSE: LXX) (OTCQB: LXRP), suspects that market-makers and broker-dealers are engaged in something potentially illegal and certainly untoward in connection with the stock of the company.
As if they weren’t sufficiently complicated already, the political and policy issues that surround the legal marijuana industry may be reshaped in the not-distant future by the politics of water.
Weekly CannaBit for the week of August 24, 2015: The volume of retail marijuana sold in Colorado increased ten-fold in the past 18 months.
The cannabis sector welcomed the successful introduction of MassRoots (OTCQB: MSRT), with shares traded comfortably above $1 with great volume.
The conference circuit is starting to heat up again as several public companies will be attending and speaking at conferences around the country for the remainder of the month.
Wow, the low levels people will reach when trying to manipulate an OTC Pink name are truly fantastic. One brand in particular has been pump-pump-pumping away for weeks.
Does anyone recall the taper tantrum from a couple of years ago? In the midst of the massive Fed money printing, there was a brief period where the markets really struggled from fear of the Fed ending quantitative easing.
Cannabis stocks are not feeling the same bullishness of broad markets. Cannabis stocks need to escape purgatory and that requires serious purging of low quality, capital-consuming cannabis stocks.
Cannabis stocks traded poorly today. Fridays are generally plagued by poor volume and price weakness. Month ends exhibit similar characteristics.
Cannabis stocks were mostly quiet today. Volume is becoming quite challenging as recent actions by the U.S. Treasury Department may take a big bite out of OTC PINK companies.
Volume is once again thinning in the cannabis sector. Risk-off sentiment in the broader markets may have a trickle-down effect on the participation in this high octane sector.
Equities continued to surge higher and recoup the recent weakness. Keep in mind that just a few days ago, the market was off to its worst start to a calendar year ever.
The S&P 500, Russell 2k and Russell MicroCap all experienced gains of > 1.7%. MJIC Marijuana Index and Benzinga 420 Marijuana Index both underperformed, with a gain of 0.09% and a decline of 1.51% respectively.